MiR-23a-3p acts as an oncogene and potential prognostic biomarker by targeting PNRC2 in RCC
- Type
- Retraction
- Notice date
- 7/5/2024 0:00
- Journal
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier
- Notice DOI
- 10.1016/j.biopha.2024.117098
- Original paper DOI
- 10.1016/j.biopha.2018.11.065
Reasons
- Duplication of/in Image
- Investigation by Third Party
- Original Data and/or Images not Provided and/or not Available
- Unreliable Results and/or Conclusions
- Updated to Retraction